HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soluble epoxide hydrolase: a new target for cardioprotection.

Abstract
Arachidonic acid is metabolized to a number of bioactive eicosanoid molecules by several enzymes, including enzymes of the COX, lipoxygenase and cytochrome P450 (CYP) monooxygenase pathways. Inhibition of the CYP omega-hydroxylase pathway, stimulation of the CYP-epoxygenase pathway and administration of exogenous epoxyeicosatrienoic acids resulted in cardioprotection in animal models of ischemia; contractile function was improved in mouse hearts subjected to global ischemia/reperfusion, and infarct size was reduced in canine and rat hearts. Cardioprotective effects were also achieved when metabolism of the endogenous epoxyeicosatrienoic acids (EETs) by their major enzymatic hydrolysis pathway was blocked in gene knockout mice (EPHX2-/-) or by inhibitors of soluble epoxide hydrolase (sEH), such as 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA). Pretreatment of canine hearts with AUDA dose-dependently reduced infarct size, and AUDA enhanced the infarct-sparing effect of treatment with exogenous EETs. The preliminary results of studies in rodent hearts have also demonstrated that AUDA and AUDA-butyl ester reduce infarct size. These results and others obtained in models of myocardial stunning and hypertrophy suggest that inhibitors of EPHX2 or sEH have therapeutic potential in a broad range of cardiovascular diseases.
AuthorsGarrett J Gross, Kasem Nithipatikom
JournalCurrent opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 10 Issue 3 Pg. 253-8 (Mar 2009) ISSN: 2040-3429 [Electronic] England
PMID19333883 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • 12-(3-adamantan-1-ylureido)dodecanoic acid
  • 12-(3-adamantan-1-ylureido)dodecanoic acid butyl ester
  • Cardiotonic Agents
  • Eicosanoids
  • Enzyme Inhibitors
  • Lauric Acids
  • Urea
  • Epoxide Hydrolases
  • Adamantane
Topics
  • Adamantane (analogs & derivatives, pharmacology)
  • Animals
  • Cardiomegaly (drug therapy, enzymology)
  • Cardiotonic Agents (pharmacology)
  • Coronary Disease (drug therapy, enzymology, physiopathology)
  • Dose-Response Relationship, Drug
  • Drug Design
  • Eicosanoids (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Epoxide Hydrolases (antagonists & inhibitors, genetics, metabolism)
  • Heart Arrest (drug therapy, enzymology)
  • Humans
  • Lauric Acids (pharmacology)
  • Mice
  • Mice, Knockout
  • Myocardial Contraction (drug effects)
  • Myocardial Infarction (drug therapy, enzymology)
  • Urea (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: